Prognostic impact of aberrant t/NK cell marker expression in AML.

被引：0
|
作者：
Saste, Abhijit Balkrishna
Gulati, Rohit
Kuriakose, Philip
Inamdar, Kedar
Karner, Kristin
Carey, John
Menon, Madhu
机构：
[1] Henry Ford Hlth Syst, Detroit, MI USA
[2] Henry Ford Hosp, Northville, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e18502
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18502
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression
    Junge, A.
    Bacher, U.
    Keller, P.
    Mueller, B. U.
    Solenthaler, M.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2018, 148 : 8S - 9S
  • [2] Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression
    Junge, Alexandra
    Bacher, Ulrike
    Mueller, Beatrice U.
    Keller, Peter
    Solenthaler, Max
    Pabst, Thomas
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (03) : 576 - 583
  • [3] Treg infiltration and the expression of immune checkpoints associated with T cell exhaustion in AML.
    Williams, Patrick
    Basu, Sreyashi
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    Ravandi, Farhad
    Jabbour, Elias
    Al-Hamal, Zainab
    Konopleva, Marina
    Ning, Jing
    Xiao, Lianchun
    Lopez, Juliana Hidalgo
    Kornblau, Steven
    Andreeff, Michael
    Bueso-Ramos, Carlos E.
    Blando, Jorge M.
    Alatrash, Gheath
    Allison, James Patrick
    Kantarjian, Hagop M.
    Sharma, Padmanee
    Daver, Naval Guastad
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Aberrant expression of β- and γ-catenin is an independent prognostic marker in oral squamous cell carcinoma
    Ueda, G
    Sunakawa, H
    Nakamori, K
    Shinya, T
    Tsuhako, W
    Tamura, Y
    Kosugi, T
    Sato, N
    Ogi, K
    Hiratsuka, H
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2006, 35 (04) : 356 - 361
  • [5] Aberrant SYK Expression As a Potential Therapeutic Target in T/NK Cell Neoplasms
    Zhang, Jing-Ping
    Gao, Qi
    Chan, Alexander
    Xiao, Wenbin
    El Daker, Sary
    Roshal, Mikhail
    Dogan, Ahmet
    BLOOD, 2019, 134
  • [6] Expression Profiling of a Hemopoietic Cell Survival Transcriptome Identifies a Functional Prognostic Gene Signature in Normal Karyotype AML.
    Guthridge, Mark
    Thomas, Daniel
    Barry, Emma F.
    Chung, Kok H.
    McClure, Barbara J.
    To, L. Bik
    Goodall, Greg
    Speed, Terry P.
    Osato, Motomi
    Haylock, David
    Nilsson, Susie
    D'Andrea, Richard
    Lopez, Angel
    Powell, Jason A.
    BLOOD, 2009, 114 (22) : 647 - 647
  • [7] Prognostic significance of progenitor cell doubling time (P-2) in AML.
    Pagliaro, LC
    Drew, MC
    Liu, B
    Freireich, EJ
    BLOOD, 1996, 88 (10) : 3361 - 3361
  • [8] Coinhibitory Expression Profiling of AML Blasts Identifies HVEM as Prognostic Marker in AML
    Lichtenegger, Felix S.
    Kondla, Isabell
    Krempasky, Michael
    Weber, Anna L.
    Schneider, Stephanie
    Spiekermann, Karsten
    Braess, Jan
    Hiddemann, Wolfgang
    Subklewe, Marion
    BLOOD, 2013, 122 (21)
  • [9] Comprehensive HOX gene expression profiles are associated with major cytogenetic prognostic categories in AML.
    Drabkin, HA
    Ruvolo, V
    Gadgil, S
    Chen, WJ
    Zeng, C
    Baron, AE
    Kornblau, SM
    Estey, E
    Coombes, KR
    Andreeff, M
    BLOOD, 2005, 106 (11) : 838A - 838A
  • [10] HOX expression patterns identify major cytogenetic groups and are of prognostic importance in adult AML.
    Andreeff, Michael
    Ruvolo, Vivian
    Gadgil, Sharvari
    Chen, Wenjing
    Coombes, Kevin
    Zeng, Chan
    Baron, Anna
    Drabkin, Harry
    BLOOD, 2006, 108 (11) : 635A - 635A
12345